Pharmacogenomics: implications for laboratory medicine

Citation
G. Schmitz et al., Pharmacogenomics: implications for laboratory medicine, CLIN CHIM A, 308(1-2), 2001, pp. 43-53
Citations number
44
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
CLINICA CHIMICA ACTA
ISSN journal
00098981 → ACNP
Volume
308
Issue
1-2
Year of publication
2001
Pages
43 - 53
Database
ISI
SICI code
0009-8981(200106)308:1-2<43:PIFLM>2.0.ZU;2-7
Abstract
Pharmacogenomics deals with the interactions of individual genetic constitu tion with drug therapy. It has potentially far reaching consequences for dr ug development and future treatment strategies, but also for clinical in vi tro diagnostics. With increasing knowledge about interactions between genes and drug treatment, there will be an equally increasing demand for rapid a nd reliable diagnostic tests prior to the institution of therapy. In fact. it is very likely that pharmacogenetic tests will make up a significant pro portion of total molecular biology testing in the coming years. Therefore, this review focuses on the implications of pharmacogenomics on the clinical laboratory. (C) 2001 Elsevier Science B.V. All rights reserved.